Aleksey Yu. Vigorov

Aleksey Yu. Vigorov

Auto-generated profile, based on publicly available information

Aleksey Yu. Vigorov

Postovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, Yekaterinburg, Russia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2015 in Catalysis Letters
Verified
Journal Article
Closed access
PDF file
OFOlga V. Fedorova
Olga V. Fedorova
YTYulia Titova
Yulia Titova
AVAlexey Yu. Vigorov
Alexey Yu. Vigorov
MTMaria S. Toporova
Maria S. Toporova
VAVolha Alisiyonak
Volha Alisiyonak
Valery N. CharushinValery N. Charushin
Valery N. Charushin

1 December 2022 in Russian Chemical Bulletin
Verified
Journal Article
Closed access
PDF file
AVA. Yu. Vigorov
A. Yu. Vigorov
INI. A. Nizova
I. A. Nizova
GLG. L. Levit
G. L. Levit
TMT. V. Matveeva
T. V. Matveeva
LSL. Sh. Sadretdinova
L. Sh. Sadretdinova
VKV. P. Krasnov
V. P. Krasnov

22 March 2011 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
AVAlexey Yu. Vigorov
Alexey Yu. Vigorov
INIrina A. Nizova
Irina A. Nizova
LSLiliya Sh. Sadretdinova
Liliya Sh. Sadretdinova
MEMarina A. Ezhikova
Marina A. Ezhikova
MKMikhail I. Kodess
Mikhail I. Kodess
VKVictor Krasnov
Victor Krasnov

1 December 2022 in Russian Chemical Bulletin
Verified
Journal Article
Closed access
PDF file
AVA. Yu. Vigorov
A. Yu. Vigorov
EGE. B. Gorbunov
E. B. Gorbunov
MEM. A. Ezhikova
M. A. Ezhikova
MKM. I. Kodess
M. I. Kodess
DBD. V. Belyaev
D. V. Belyaev
VKV. P. Krasnov
V. P. Krasnov

2 November 2023 in Molecules
Verified
Journal Article
Open access
PDF file
VKVictor Krasnov
Victor Krasnov
INIrina A. Nizova
Irina A. Nizova
AVAlexey Yu. Vigorov
Alexey Yu. Vigorov
TMTatyana V. Matveeva
Tatyana V. Matveeva
GLGalina L. Levit
Galina L. Levit
Valery N. CharushinValery N. Charushin
Valery N. Charushin
Venous thromboembolism is a serious problem because it significantly increases the risk of developing vascular complications in elderly patients with obesity or immobilization, cancer, and many other diseases. Thus, there is a need to study new therapeutic strategies, including new medicinal agents for the efficient and safe correction of thrombus disorders. In this work, we have synthesized a number of new amides and peptides of 4-amino-5-oxoprolines and studied their antiplatelet and antithrombotic activity in experiments in vitro and in vivo. It has been found that the newly obtained compounds slow down the process of thrombus formation in a model of arterial and venous thrombosis, without affecting plasma hemostasis parameters. (2S,4S)-4-Amino-1-(4-fluorophenyl)-5-oxoprolyl-(S)-phenylalanine proved to be the most efficient among the studied derivatives. The results obtained indicate the advisability of further studies on 5-oxoproline derivatives in order to design pharmaceutical agents for the prevention and treatment of the consequences of thrombosis.

1 June 2014 in Russian Chemical Bulletin
Verified
Journal Article
Closed access
PDF file
AVA. Yu. Vigorov
A. Yu. Vigorov
INI. A. Nizova
I. A. Nizova
ATA. A. Tumashov
A. A. Tumashov
MEM. A. Ezhikova
M. A. Ezhikova
MKM. I. Kodess
M. I. Kodess
VKVictor Krasnov
Victor Krasnov